Neuropathology of dementia in Parkinson's disease: A prospective, community-based study - Wikidata - wikimedia - TriplyDB

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

http://www.wikidata.org/entity/Q57915620

about

Neuropathology of non-Alzheimer degenerative disorders Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease Cognitive profile of LRRK2-related Parkinson's disease Parkinson Disease and Dementia.Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells.Profile of cognitive impairment in Parkinson's disease Neuropathologic substrates of Parkinson disease dementia.Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.Mapping cortical atrophy in Parkinson's disease patients with dementia.The neurobiological basis of cognitive impairment in Parkinson's disease.Biomarkers for cognitive impairment in Parkinson disease.Pathologic correlates of dementia in individuals with Lewy body disease.Parkinson's disease: the quintessential neuropsychiatric disorder Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia.Amyloid imaging of Lewy body-associated disorders Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?An update on brain imaging in parkinsonian dementia Neural substrates of cognitive subtypes in Parkinson's disease: a 3-year longitudinal study.Cognitive profiles in Parkinson's disease and their relation to dementia: a data-driven approach.Seniors with Parkinson's disease: initial medical treatment.Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment.Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions.Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease.Cognitive reserve and β-amyloid pathology in Parkinson disease Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry Insomnia in Parkinson's disease: frequency and progression over time Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice.

P2860

Q24657571-599350AF-23AB-42C3-B56F-B8FAD9BA8F7D Q26744782-E05C36D2-98BA-4DDB-8BE4-24BBE97C92D6 Q27333093-8A0EB5F9-DA80-48C3-804F-58571520A873 Q30248574-07307118-A6DD-473F-ADED-85A125A27249 Q30437451-AC7D7842-D459-46DD-8374-24D27C48B729 Q30438194-CB401B90-4DC9-420C-97CA-4BA436B1FAC4 Q30440337-127299A8-8AEB-43D6-AAC8-95F4052CEAA3 Q30498333-1085B7B5-3100-498C-B6AD-D1AA09969B88 Q30527797-989F3014-8B38-4323-BA97-F5CE0D9AE5C1 Q31097119-F3431C14-BD4B-43BD-9839-B1F227389143 Q33522039-9E9CA8C1-69B0-4B9D-8020-594BBC814D60 Q33599010-45601E3F-A83D-4DA3-B342-5CEB844D20B0 Q33724698-0E92B0B4-7A1F-4D91-BFB2-3D539A5B6D5B Q33896664-62DD912C-6409-4610-82F1-FE06943CB780 Q33896668-691B43F7-745E-443F-AC6B-BABF134AD505 Q33917094-ED01AF2C-3F20-427A-A81B-F18014CB11AD Q34080479-5A647679-52A8-4FCE-A01E-360F4F48839A Q34111474-247C6BFE-CB29-4278-85B2-088BFEBF0244 Q34300244-CD0A77EB-7610-423D-AFF1-6F60EE471B5F Q34327102-1DFB65FF-ADD7-4168-8BBB-AD0762CDF5D6 Q34327937-0F565A21-84DC-43FF-8A4C-FFC641D0B5AF Q34374245-19D6BD62-E87A-41A6-85C4-09D557452A92 Q34465488-25D505A3-CAD3-4E73-A8E0-8CEF6AE69E8E Q34508143-995A7ABB-A926-449A-8CF0-98F229A649E0 Q34575656-307C0AFD-502D-4288-BA62-F62FA8A23711 Q35002066-2E608596-4344-4969-9026-854FCE066EB3 Q35158915-39358F4B-0B11-425E-93FB-74E04548E92D Q35550727-9980D5CA-7E19-4243-89E2-395BDA279B9D Q35679817-56EC54B9-CCCD-4DCF-9226-D080529D9CEA Q35875396-C87E1B6E-9B60-48CC-843C-CB683288C146 Q36004081-5F99BAC8-8B3A-4C38-B8D7-D38D9E8EEFA5 Q36004679-B7E226B5-03E1-43C0-BC3A-239BDB3AC585 Q36175217-F765CE1A-CC0B-4C76-84EA-76D087B16449 Q36178474-2AC5D8E6-F975-4A16-BBB3-0625438BE26E Q36179280-DE9721C9-249B-4C66-81FD-ACF9B446D8E3 Q36226890-702311B0-4946-40F5-9116-019913404C2A Q36227480-7C254CB2-2C19-4E97-989A-5F8E55199836 Q36373719-AEB080FE-1692-457A-B167-804E4B46B7D8 Q36475260-761D1579-13BE-4748-B9A5-A31984427AFE Q36486037-FAD56F15-F03B-4C40-9AEE-5FA7BFB5C02E

P2860

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

http://www.wikidata.org/entity/Q57915620

description

article

@en

im Januar 2005 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2005

@uk

name

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

@en

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

@nl

type

label

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

@en

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

@nl

prefLabel

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

@en

Neuropathology of dementia in Parkinson's disease: A prospective, community-based study

@nl

P1433

Q57915620-8107034F-F523-4EA0-8ED0-0C6167316B62

P1476

Q57915620-B8FC0741-BBE8-4195-99F3-468B4657F9F3

P2093

Q57915620-9105D7DE-44A0-488E-BC69-67FE88D094D6

Q57915620-91F5B1AD-1A90-49E3-A329-CFA20DB56016

Q57915620-D160CDCF-1C46-4CFA-933C-F2BFDC9DF154

P2860

Q57915620-05D9F630-FA3F-46C3-B374-6637928ADBAC

Q57915620-8E00D58F-81B4-4279-ADB5-9A87A28319EF

P304

Q57915620-0569076C-BAC2-4AE0-BD00-476460AC6791

P31

Q57915620-275D9D56-1899-41FB-BAFD-F4F852B5050B

P356

Q57915620-B2644304-859B-4E49-A580-EA8927BA328C

P433

Q57915620-FFCC4F09-7F77-4493-A342-42818E063A0A

P478

Q57915620-A0B4C31D-D58A-4054-8F41-59FD1939A318

P50

Q57915620-94E94AA6-60CF-474D-AFD2-453C87BB6812

Q57915620-A600A848-6FFE-4756-9ED8-612D51943B66

P577

Q57915620-6EA9B866-E809-480D-BD7F-109CE9487649

P698

Q57915620-77859910-95EC-4F81-9F7D-AEE394C58FC2

P921

Q57915620-723CB895-A83F-41F2-B320-C9798E4D4464

Q57915620-7CAA4910-5EE6-48D2-8957-7E07899A8591

P356

P1433

Annals of Neurology

P1476

Neuropathology of dementia in Parkinson's disease: a prospective, community-based study

@en

P2093

Andrew Brown

http://www.w3.org/2001/XMLSchema#string

Jan P Larsen

http://www.w3.org/2001/XMLSchema#string

Robert Perry

http://www.w3.org/2001/XMLSchema#string

P2860

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

P304

773-776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.20635

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16240351

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease